July 8, 2020 / 12:45 PM / a month ago

BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic

July 8 (Reuters) - Guardant Health Inc:

* GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC

* GUARDANT HEALTH - TO PURSUE REGULATORY APPROVAL AND COMMERCIALIZATION OF GUARDANT360 CDX AS A COMPANION DIAGNOSTIC FOR AMIVANTAMAB

* GUARDANT HEALTH INC - AGREEMENT COVERS UNITED STATES, CANADA, JAPAN, AND EUROPE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below